Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionWnt receptor activity

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.19e-12171007GO:0042813
GeneOntologyMolecularFunctionG protein-coupled receptor activity

GPR19 GPR65 GPR50 PDGFRB FFAR3 GPR42 OR9Q2 OR4E2 GRIK3 TAAR8 OR10D3 FZD1 FZD4 OR10G6 FZD6 FZD7 FZD9 OR10G3 P2RY4 FZD5 OR52H1 MTNR1B OR4D5 FZD2

7.65e-1288410024GO:0004930
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

GABRG1 GPR19 GPR65 GPR50 PDGFRB FFAR3 GPR42 OR9Q2 OR4E2 GRIK3 TAAR8 CHRNA4 CHRNE OR10D3 FZD1 FZD4 OR10G6 FZD6 FZD7 FZD9 LIFR OR10G3 P2RY4 FZD5 OR52H1 MTNR1B OR4D5 FZD2

6.05e-11135310028GO:0004888
GeneOntologyMolecularFunctionWnt-protein binding

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

3.07e-10341007GO:0017147
GeneOntologyMolecularFunctionmelatonin receptor activity

GPR50 MTNR1B

1.48e-0441002GO:0008502
GeneOntologyMolecularFunctiontransmitter-gated channel activity

GABRG1 GRIK3 CHRNA4 CHRNE

3.17e-04651004GO:0022835
GeneOntologyMolecularFunctiontransmitter-gated monoatomic ion channel activity

GABRG1 GRIK3 CHRNA4 CHRNE

3.17e-04651004GO:0022824
GeneOntologyMolecularFunctionextracellular ligand-gated monoatomic ion channel activity

GABRG1 GRIK3 CHRNA4 CHRNE

6.06e-04771004GO:0005230
GeneOntologyBiologicalProcessG protein-coupled receptor signaling pathway

GPR19 GPR65 GPR50 PDGFRB FFAR3 GPR42 OR9Q2 OR4E2 GRIK3 TSHB CAV1 TAAR8 OR10D3 FZD1 FZD4 OR10G6 FZD6 FZD7 FZD9 OR10G3 P2RY4 FZD5 OR52H1 MTNR1B OR4D5 LYN FZD2

4.04e-10139510127GO:0007186
GeneOntologyBiologicalProcessnon-canonical Wnt signaling pathway

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

9.93e-08771017GO:0035567
GeneOntologyBiologicalProcessregulation of membrane potential

GABRG1 FFAR3 GPR42 GRIK3 CAV1 CHRNA4 KCNH3 CHRNE SLC6A4 FZD9 MTNR1B ATP1A4

1.86e-0555910112GO:0042391
GeneOntologyBiologicalProcesscellular response to retinoic acid

YES1 FZD4 SLC6A4 FZD7 LYN

2.94e-05731015GO:0071300
GeneOntologyBiologicalProcesspositive regulation of transmission of nerve impulse

FFAR3 GPR42 MTNR1B

3.15e-05131013GO:0051971
GeneOntologyBiologicalProcessregulation of MAP kinase activity

DIRAS1 PDGFRB CAV1 FZD4 FZD5 LYN DIRAS2

4.77e-051941017GO:0043405
GeneOntologyBiologicalProcesscanonical Wnt signaling pathway

CAV1 SCYL2 FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.88e-053441019GO:0060070
GeneOntologyBiologicalProcessregulation of neuronal action potential

FFAR3 GPR42 MTNR1B

4.97e-05151013GO:0098908
GeneOntologyBiologicalProcesspositive regulation of acute inflammatory response to non-antigenic stimulus

FFAR3 GPR42

7.10e-0531012GO:0002879
GeneOntologyBiologicalProcessregulation of acute inflammatory response to non-antigenic stimulus

FFAR3 GPR42

1.42e-0441012GO:0002877
GeneOntologyBiologicalProcessWnt signaling pathway, planar cell polarity pathway

FZD1 FZD6 FZD7 FZD2

1.52e-04551014GO:0060071
GeneOntologyBiologicalProcessWnt signaling pathway

CAV1 SCYL2 FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2 ALPK2

2.21e-0451610110GO:0016055
GeneOntologyBiologicalProcessacute inflammatory response to non-antigenic stimulus

FFAR3 GPR42

2.35e-0451012GO:0002525
GeneOntologyBiologicalProcessneuronal action potential

FFAR3 GPR42 CHRNA4 MTNR1B

2.58e-04631014GO:0019228
GeneOntologyBiologicalProcessmonoamine transport

SLC29A3 FFAR3 GPR42 CHRNA4 SLC6A4

2.66e-041161015GO:0015844
GeneOntologyBiologicalProcessmembrane depolarization

CAV1 CHRNA4 CHRNE SLC6A4 FZD9

3.23e-041211015GO:0051899
GeneOntologyBiologicalProcessregulation of transmission of nerve impulse

FFAR3 GPR42 MTNR1B

3.42e-04281013GO:0051969
GeneOntologyBiologicalProcessmuscular septum morphogenesis

FZD1 FZD2

3.52e-0461012GO:0003150
GeneOntologyBiologicalProcesspositive regulation of neuronal action potential

FFAR3 GPR42

3.52e-0461012GO:1904457
GeneOntologyCellularComponentacetylcholine-gated channel complex

STXBP5 CHRNA4 CHRNE

8.47e-05181013GO:0005892
GeneOntologyCellularComponentmonoatomic ion channel complex

GABRG1 CATSPERD STXBP5 BEST3 GRIK3 CHRNA4 KCNH3 CHRNE

4.97e-043781018GO:0034702
GeneOntologyCellularComponentcytoplasmic vesicle membrane

SLC29A3 STAB2 STXBP5 CAV1 DCST2 DENND1A SCYL2 FZD4 FZD6 SLC6A4 FZD7 CMTM6 FZD5 SLC45A2 LYN FZD2

5.14e-04130710116GO:0030659
GeneOntologyCellularComponentendocytic vesicle membrane

STAB2 CAV1 FZD4 FZD5 LYN FZD2

5.77e-042121016GO:0030666
GeneOntologyCellularComponentvesicle membrane

SLC29A3 STAB2 STXBP5 CAV1 DCST2 DENND1A SCYL2 FZD4 FZD6 SLC6A4 FZD7 CMTM6 FZD5 SLC45A2 LYN FZD2

5.97e-04132510116GO:0012506
GeneOntologyCellularComponentSAGA-type complex

ZZZ3 TAF2 KAT14

8.82e-04391013GO:0070461
GeneOntologyCellularComponentcell surface

STAB2 PDGFRB CAV1 CHRNA4 FZD1 FZD4 FZD6 FZD9 LIFR SCUBE1 SCUBE2 FZD5 SCUBE3 LYN

8.99e-04111110114GO:0009986
GeneOntologyCellularComponenttransmembrane transporter complex

GABRG1 CATSPERD STXBP5 BEST3 GRIK3 CHRNA4 KCNH3 CHRNE ATP1A4

9.75e-045231019GO:1902495
GeneOntologyCellularComponentclathrin-coated vesicle

DENND1A SCYL2 FZD4 CPNE6 FZD5 FZD2

1.03e-032371016GO:0030136
GeneOntologyCellularComponenttransporter complex

GABRG1 CATSPERD STXBP5 BEST3 GRIK3 CHRNA4 KCNH3 CHRNE ATP1A4

1.38e-035501019GO:1990351
GeneOntologyCellularComponentclathrin-coated endocytic vesicle

FZD4 CPNE6 FZD5 FZD2

1.46e-031011014GO:0045334
GeneOntologyCellularComponentcytoplasmic ubiquitin ligase complex

ATG3 OS9

2.03e-03141012GO:0000153
GeneOntologyCellularComponentATAC complex

ZZZ3 KAT14

2.03e-03141012GO:0140672
GeneOntologyCellularComponentsynaptic membrane

GABRG1 ANK1 STXBP5 GRIK3 DENND1A CHRNA4 CHRNE SLC6A4 P2RY4

2.06e-035831019GO:0097060
GeneOntologyCellularComponentpresynaptic membrane

STXBP5 GRIK3 DENND1A CHRNA4 SLC6A4 P2RY4

2.27e-032771016GO:0042734
DomainFrizzled

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.65e-1411977IPR000539
DomainFrizzled

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.65e-1411977PF01534
DomainFrizzled

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.65e-1411977SM01330
DomainFrizzled/SFRP

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

9.00e-1316977IPR015526
DomainFRI

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

6.00e-1220977SM00063
Domain-

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

8.96e-12219771.10.2000.10
DomainFrizzled_dom

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.63e-1124977IPR020067
DomainFZ

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.63e-1124977PS50038
DomainFz

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.63e-1124977PF01392
DomainGPCR_2-like

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.52e-0860977IPR017981
DomainG_PROTEIN_RECEP_F2_4

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.84e-0861977PS50261
DomainEGF_3

STAB2 SCUBE1 SCUBE2 SCUBE3

3.28e-0712974PF12947
DomainEGF_dom

STAB2 SCUBE1 SCUBE2 SCUBE3

3.28e-0712974IPR024731
DomainGPCR_2_secretin-like

FZD1 FZD4 FZD6 FZD7 FZD9 FZD2

6.70e-0760976IPR000832
DomainEGF_1

LAMB4 STAB2 LAMA2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S USH2A

8.37e-072559710PS00022
DomainEGF_CA

STAB2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

3.37e-06122977SM00179
DomainEGF-like_Ca-bd_dom

STAB2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

3.76e-06124977IPR001881
DomainCUB

SCUBE1 SCUBE2 TLL1 SCUBE3 C1S

5.42e-0649975PF00431
DomainEGF_CA

SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

5.65e-0686976PF07645
DomainCUB

SCUBE1 SCUBE2 TLL1 SCUBE3 C1S

6.00e-0650975SM00042
Domain-

SCUBE1 SCUBE2 TLL1 SCUBE3 C1S

7.30e-06529752.60.120.290
DomainCUB

SCUBE1 SCUBE2 TLL1 SCUBE3 C1S

8.02e-0653975PS01180
DomainEGF-like_CS

LAMB4 STAB2 LAMA2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

8.67e-06261979IPR013032
DomainEGF_2

LAMB4 STAB2 LAMA2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

9.79e-06265979PS01186
Domain7tm_1

GPR19 GPR65 GPR50 FFAR3 GPR42 OR9Q2 OR4E2 TAAR8 OR10G6 OR10G3 P2RY4 OR52H1 MTNR1B OR4D5

1.02e-056779714PF00001
DomainEGF_Ca-bd_CS

SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

1.13e-0597976IPR018097
DomainCUB_dom

SCUBE1 SCUBE2 TLL1 SCUBE3 C1S

1.15e-0557975IPR000859
DomainG_PROTEIN_RECEP_F1_1

GPR19 GPR65 GPR50 FFAR3 GPR42 OR9Q2 OR4E2 TAAR8 OR10G6 OR10G3 P2RY4 OR52H1 MTNR1B OR4D5

1.17e-056859714PS00237
DomainEGF_CA

SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

1.27e-0599976PS01187
DomainG_PROTEIN_RECEP_F1_2

GPR19 GPR65 GPR50 FFAR3 GPR42 OR9Q2 OR4E2 TAAR8 OR10G6 OR10G3 P2RY4 OR52H1 MTNR1B OR4D5

1.29e-056919714PS50262
DomainGPCR_Rhodpsn

GPR19 GPR65 GPR50 FFAR3 GPR42 OR9Q2 OR4E2 TAAR8 OR10G6 OR10G3 P2RY4 OR52H1 MTNR1B OR4D5

1.31e-056929714IPR000276
DomainEGF_LAM_2

LAMB4 STAB2 LAMA2 USH2A

1.69e-0530974PS50027
DomainEGF_LAM_1

LAMB4 STAB2 LAMA2 USH2A

1.69e-0530974PS01248
DomainEGF-type_Asp/Asn_hydroxyl_site

SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

1.88e-05106976IPR000152
DomainEphrin_rec_like

SCUBE1 SCUBE2 SCUBE3

2.17e-0511973PF07699
DomainEGF_Lam

LAMB4 STAB2 LAMA2 USH2A

3.16e-0535974SM00180
DomainLaminin_EGF

LAMB4 STAB2 LAMA2 USH2A

4.41e-0538974IPR002049
DomainEGF-like_dom

STAB2 LAMA2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

4.64e-05249978IPR000742
DomainLaminin_N

LAMB4 LAMA2 USH2A

7.24e-0516973IPR008211
DomainLAMININ_NTER

LAMB4 LAMA2 USH2A

7.24e-0516973PS51117
DomainLaminin_N

LAMB4 LAMA2 USH2A

7.24e-0516973PF00055
DomainLamNT

LAMB4 LAMA2 USH2A

7.24e-0516973SM00136
DomainMelatonin_rcpt

GPR50 MTNR1B

7.98e-053972IPR000025
DomainGPR40-rel_orph

FFAR3 GPR42

1.59e-044972IPR013312
DomainASX_HYDROXYL

SCUBE1 SCUBE2 SUSD1 SCUBE3 C1S

1.74e-04100975PS00010
DomainGPCR_Rhodpsn_7TM

GPR19 GPR65 GPR50 FFAR3 OR9Q2 OR4E2 TAAR8 OR10G3 P2RY4 OR52H1 MTNR1B OR4D5

1.81e-046709712IPR017452
DomainEGF_3

STAB2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3 C1S

2.24e-04235977PS50026
DomainEGF

STAB2 LAMA2 SCUBE1 SCUBE2 SUSD1 TLL1 SCUBE3

2.24e-04235977SM00181
DomainEphrin_rec_like

SCUBE1 SCUBE2 SCUBE3

2.87e-0425973SM01411
DomainTyr-kin_ephrin_A/B_rcpt-like

SCUBE1 SCUBE2 SCUBE3

2.87e-0425973IPR011641
DomaincEGF

SCUBE1 SCUBE2 SCUBE3

3.24e-0426973IPR026823
DomaincEGF

SCUBE1 SCUBE2 SCUBE3

3.24e-0426973PF12662
DomainHEAT_REPEAT

TNPO2 PPP4R4 SCYL2 IPO11

4.82e-0470974PS50077
DomainEGF

STAB2 SCUBE2 TLL1 SCUBE3 C1S

5.07e-04126975PF00008
DomainLaminin_EGF

LAMB4 LAMA2 USH2A

7.88e-0435973PF00053
DomainGrowth_fac_rcpt_

STAB2 SCUBE1 SCUBE2 SUSD1 SCUBE3

1.32e-03156975IPR009030
Domain-

STAB2 SUSD1

1.42e-03119722.40.155.10
DomainGFP-like

STAB2 SUSD1

1.42e-0311972IPR023413
DomainNeurotransmitter_ion_chnl_CS

GABRG1 CHRNA4 CHRNE

1.65e-0345973IPR018000
DomainNeur_chan_memb

GABRG1 CHRNA4 CHRNE

1.75e-0346973PF02932
DomainNeur_chan_LBD

GABRG1 CHRNA4 CHRNE

1.87e-0347973PF02931
DomainNEUROTR_ION_CHANNEL

GABRG1 CHRNA4 CHRNE

1.87e-0347973PS00236
DomainNeurotrans-gated_channel_TM

GABRG1 CHRNA4 CHRNE

1.87e-0347973IPR006029
Domain-

GABRG1 CHRNA4 CHRNE

1.87e-03479732.70.170.10
DomainNeur_channel

GABRG1 CHRNA4 CHRNE

1.87e-0347973IPR006201
DomainNeur_chan_lig-bd

GABRG1 CHRNA4 CHRNE

1.87e-0347973IPR006202
DomainIMPORTIN_B_NT

TNPO2 IPO11

2.33e-0314972PS50166
DomainIBN_N

TNPO2 IPO11

2.68e-0315972PF03810
Domain7TM_GPCR_Srsx

GPR19 GPR50 TAAR8 MTNR1B

2.77e-03112974SM01381
DomainIBN_N

TNPO2 IPO11

3.06e-0316972SM00913
DomainNicotinic_acetylcholine_rcpt

CHRNA4 CHRNE

3.06e-0316972IPR002394
DomainHEAT

TNPO2 SCYL2 IPO11

3.41e-0358973IPR000357
DomainImportin-beta_N

TNPO2 IPO11

3.45e-0317972IPR001494
PathwayKEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.40e-1314797M47834
PathwayKEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.45e-1216797M47823
PathwayKEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

6.32e-1219797M47833
PathwayPID_WNT_SIGNALING_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.43e-1028797M77
PathwayWP_WNT_SIGNALING_IN_KIDNEY_DISEASE

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

9.69e-1036797M39699
PathwayWP_GPCRS_NONODORANT

GPR65 GPR50 FFAR3 GPR42 FZD1 FZD4 FZD6 FZD7 FZD9 P2RY4 FZD5 MTNR1B FZD2

2.50e-092667913MM15843
PathwayWP_WNT_SIGNALING_IN_KIDNEY_DISEASE

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.29e-0944797MM15878
PathwayKEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

5.06e-0945797M47412
PathwayKEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

5.94e-0946797M47409
PathwayWP_ESC_PLURIPOTENCY_PATHWAYS

PDGFRB FZD1 FZD4 FZD6 FZD7 FZD9 LIFR FZD5 FZD2

1.61e-08116799MM15863
PathwayWP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS

PDGFRB FZD1 FZD4 FZD6 FZD7 FZD9 LIFR FZD5 FZD2

1.73e-08117799M39530
PathwayKEGG_BASAL_CELL_CARCINOMA

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.16e-0855797M17807
PathwayWP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

7.91e-0866797M39642
PathwayWP_WNT_SIGNALING_AND_PLURIPOTENCY

PPM1J FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

8.99e-08101798M39387
PathwayWP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY

PPM1J FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

8.99e-08101798MM15829
PathwayREACTOME_PCP_CE_PATHWAY

PSMA7 FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

4.60e-0785797MM15041
PathwayWP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.60e-0785797M48315
PathwayREACTOME_PCP_CE_PATHWAY

PSMA7 FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

7.92e-0792797M27322
PathwayPID_WNT_NONCANONICAL_PATHWAY

YES1 FZD6 FZD7 FZD5 FZD2

8.70e-0732795M23
PathwayREACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

9.17e-0794797M797
PathwayREACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS

PSMA7 FZD1 FZD4 FZD7 FZD5 FZD2

1.01e-0660796MM15150
PathwayWP_WNT_SIGNALING

FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

1.11e-0661796MM15893
PathwayREACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS

PSMA7 FZD1 FZD4 FZD7 FZD5 FZD2

1.48e-0664796M27396
PathwayKEGG_MELANOGENESIS

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.49e-06101797M7761
PathwayREACTOME_GPCR_LIGAND_BINDING

GPR65 FFAR3 TSHB TAAR8 FZD1 FZD4 FZD6 FZD7 FZD9 P2RY4 FZD5 MTNR1B FZD2

1.60e-064637913M507
PathwayWP_WNT_SIGNALING_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.65e-06110797MM15977
PathwayWP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.24e-06118797M39852
PathwayREACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING

PSMA7 FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

5.59e-06123797MM14988
PathwayREACTOME_SIGNALING_BY_RNF43_MUTANTS

FZD4 FZD6 FZD5

9.30e-068793M27433
PathwayWP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA

FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

1.03e-0589796M39563
PathwayWNT_SIGNALING

FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

1.03e-0589796M5493
PathwayKEGG_PATHWAYS_IN_CANCER

LAMB4 PDGFRB LAMA2 FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.30e-053257910M12868
PathwayWP_GPCRS_OTHER

FZD1 FZD7 FZD9 FZD5 MTNR1B FZD2

1.59e-0596796MM15939
PathwayREACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING

PSMA7 FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

1.72e-05146797M27288
PathwayWP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER

FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

1.79e-0598796M39731
PathwayKEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION

GABRG1 GPR50 GRIK3 TSHB TAAR8 CHRNA4 CHRNE P2RY4 MTNR1B

2.05e-05272799M13380
PathwayKEGG_WNT_SIGNALING_PATHWAY

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.14e-05151797M19428
PathwayREACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE

CAV1 FZD1 FZD5 FZD2

2.56e-0531794M27400
PathwayREACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE

CAV1 FZD1 FZD5 FZD2

2.56e-0531794MM15154
PathwayREACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT

PSMA7 CAV1 FZD1 FZD4 FZD6 FZD5 FZD2

2.87e-05158797MM14791
PathwayWP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

3.24e-05161797M39770
PathwayWP_WNT_SIGNALING_WP428

FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

4.01e-05113796M39669
PathwayREACTOME_SIGNALING_BY_WNT

PSMA7 CAV1 FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

5.62e-05239798MM14756
PathwayREACTOME_CA2_PATHWAY

FZD4 FZD6 FZD5 FZD2

1.14e-0445794MM15040
PathwayREACTOME_SIGNALING_BY_GPCR

GPR65 FFAR3 TSHB TAAR8 FZD1 FZD4 FZD6 FZD7 FZD9 P2RY4 FZD5 MTNR1B FZD2

1.31e-047027913M746
PathwayREACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION

FZD4 FZD6 FZD5

1.80e-0420793MM15155
PathwayPID_PTP1B_PATHWAY

PDGFRB CAV1 YES1 LYN

2.02e-0452794M50
PathwayREACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION

FZD4 FZD6 FZD5

2.09e-0421793M27401
PathwayWP_BREAST_CANCER_PATHWAY

FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

2.22e-04154796M39739
PathwayREACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT

PSMA7 CAV1 FZD1 FZD4 FZD6 FZD5 FZD2

3.25e-04233797M27099
PathwayREACTOME_CA2_PATHWAY

FZD4 FZD6 FZD5 FZD2

3.98e-0462794M27321
PathwayREACTOME_SIGNALING_BY_WNT

PSMA7 CAV1 FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

5.10e-04330798M7847
PathwayWP_CANCER_PATHWAYS

LAMB4 PDGFRB LAMA2 FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

5.14e-045077910M48302
PathwayWP_GPCRS_CLASS_A_RHODOPSINLIKE

GPR19 GPR65 GPR50 FFAR3 GPR42 P2RY4 MTNR1B

6.27e-04260797M39397
PathwayREACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS

CHRNA4 CHRNE

6.39e-047792M27596
PathwayREACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS

CHRNA4 CHRNE

6.39e-047792MM15311
PathwayWP_ALZHEIMERS_DISEASE

PSMA7 FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

6.41e-04261797M42565
PathwayREACTOME_SIGNALING_BY_WNT_IN_CANCER

FZD4 FZD6 FZD5

8.94e-0434793M27405
PathwayREACTOME_PECAM1_INTERACTIONS

YES1 LYN

1.97e-0312792MM14835
PathwayREACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS

CHRNA4 CHRNE

1.97e-0312792M48008
PathwayREACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2

FZD5 FZD2

1.97e-0312792MM15163
PathwayREACTOME_PECAM1_INTERACTIONS

YES1 LYN

1.97e-0312792M11773
PathwayWP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS

PSMA7 FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

2.31e-03326797M39379
PathwayREACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2

FZD5 FZD2

2.32e-0313792M27415
PathwayREACTOME_REGULATION_OF_KIT_SIGNALING

YES1 LYN

2.32e-0313792MM14565
PathwayREACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS

GPR65 FFAR3 GPR42 TSHB TAAR8 P2RY4 MTNR1B

2.60e-03333797MM14963
PathwayBIOCARTA_AKAPCENTROSOME_PATHWAY

NUP85 PKN1

2.70e-0314792M15347
PathwayREACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS

CHRNA4 CHRNE

2.70e-0314792M757
PathwayREACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS

CHRNA4 CHRNE

3.11e-0315792MM14704
PathwayWP_PLEURAL_MESOTHELIOMA

PDGFRB LAMA2 FZD1 FZD6 FZD7 FZD9 FZD5 FZD2

3.13e-03439798M42563
Pubmed

Expression of Frizzled genes in developing and postnatal hair follicles.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.80e-1610102715245425
Pubmed

Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.95e-1611102724860427
Pubmed

Expression of Frizzled5, Frizzled7, and Frizzled10 during early mouse development and interactions with canonical Wnt signaling.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.95e-1611102717576136
Pubmed

Distinct but redundant expression of the Frizzled Wnt receptor genes at signaling centers of the developing mouse brain.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

4.95e-1611102717582687
Pubmed

Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R).

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5

3.83e-157102615370539
Pubmed

Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5

1.53e-148102610559494
Pubmed

A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals.

FZD1 FZD4 FZD7 FZD9 FZD5 FZD2

4.57e-14910269707618
Pubmed

Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.

FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

1.14e-1310102617532316
Pubmed

Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women.

FZD1 FZD6 FZD7 FZD9 FZD5

1.96e-135102519543507
Pubmed

Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.49e-1322102717064353
Pubmed

Molecular determinants of WNT9b responsiveness in nephron progenitor cells.

FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

2.50e-1311102630978219
Pubmed

A role for Wnt/beta-catenin signaling in lens epithelial differentiation.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

6.97e-1325102712812787
Pubmed

3D representation of Wnt and Frizzled gene expression patterns in the mouse embryo at embryonic day 11.5 (Ts19).

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.24e-1229102718364260
Pubmed

Wnt/Rspondin/β-catenin signals control axonal sorting and lineage progression in Schwann cell development.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.18e-1136102724151333
Pubmed

Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.45e-1137102715342465
Pubmed

Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.45e-1137102718800919
Pubmed

Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.77e-1138102721041481
Pubmed

Tissue-specific requirements of beta-catenin in external genitalia development.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.77e-1138102718635608
Pubmed

Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

8.65e-1147102728813421
Pubmed

Malformation of Tear Ducts Underlies the Epiphora and Precocious Eyelid Opening in Prickle 1 Mutant Mice: Genetic Implications for Tear Duct Genesis.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

8.65e-1147102733141892
Pubmed

Members of the WNT signaling pathways are widely expressed in mouse ovaries, oocytes, and cleavage stage embryos.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

8.65e-1147102718351675
Pubmed

Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.18e-1049102719562671
Pubmed

Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation.

FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

9.94e-1036102612412008
Pubmed

Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families.

FZD1 FZD4 FZD7 FZD5 FZD2

1.18e-0917102528733458
Pubmed

Integrated analysis of Wnt signalling system component gene expression.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5

1.18e-0937102635831952
Pubmed

Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells.

FZD1 FZD6 FZD7 FZD5 FZD2

2.21e-0919102521623369
Pubmed

A coated vesicle-associated kinase of 104 kDa (CVAK104) induces lysosomal degradation of frizzled 5 (Fzd5).

SCYL2 FZD1 FZD4 FZD5

4.84e-098102419643732
Pubmed

Sequence requirement and subtype specificity in the high-affinity interaction between human frizzled and dishevelled proteins.

FZD1 FZD4 FZD7 FZD2

4.84e-098102419388021
Pubmed

Brg1 plays an essential role in development and homeostasis of the duodenum through regulation of Notch signaling.

FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

7.85e-0950102627510977
Pubmed

WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth.

TSHB FZD1 FZD4 FZD6 FZD9 FZD2

7.85e-0950102618351662
Pubmed

A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors.

FZD4 FZD6 FZD7 FZD5 FZD2

7.99e-092410259096311
Pubmed

A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled.

FZD4 FZD6 FZD7 FZD5 FZD2

7.99e-092410258626800
Pubmed

Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95.

FZD1 FZD4 FZD7 FZD2

8.69e-099102412067714
Pubmed

A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells.

FZD4 FZD6 FZD7 FZD5

8.69e-09910249160667
Pubmed

Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7.

FZD1 FZD7 FZD2

2.45e-08310239813155
Pubmed

Identification of a novel family of cell-surface proteins expressed in human vascular endothelium.

SCUBE1 SCUBE2 SCUBE3

2.45e-083102312270931
Pubmed

The relationship of serum SCUBE-1, -2 and -3 levels with clinical findings and ultrasonographic skin thickness in systemic sclerosis patients.

SCUBE1 SCUBE2 SCUBE3

2.45e-083102331991528
Pubmed

Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.

FZD1 FZD7 FZD2

2.45e-083102327680706
Pubmed

PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

5.77e-08117102717145500
Pubmed

Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling.

FZD4 FZD6 FZD5

9.78e-084102318234671
Pubmed

Scube3 is expressed in multiple tissues during development but is dispensable for embryonic survival in the mouse.

SCUBE1 SCUBE2 SCUBE3

2.44e-075102323383134
Pubmed

Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner.

FZD4 FZD6 FZD7

2.44e-075102310395542
Pubmed

Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.

FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

2.80e-0790102619515997
Pubmed

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.

FZD4 FZD7 FZD2

4.87e-076102320802536
Pubmed

FZD2 regulates limb development by mediating β-catenin-dependent and -independent Wnt signaling pathways.

FZD1 FZD7 FZD2

4.87e-076102336867021
Pubmed

Two additional protein-tyrosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase.

PDGFRB YES1 LYN

4.87e-07610231720539
Pubmed

Disruption of Scube2 Impairs Endochondral Bone Formation.

SCUBE1 SCUBE2 SCUBE3

8.50e-077102325639508
Pubmed

Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.

FZD1 FZD4 FZD7

8.50e-077102315923619
Pubmed

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action.

FZD7 FZD9 FZD5

8.50e-07710239192640
Pubmed

MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap.

FZD4 FZD7 FZD5

8.50e-077102315195140
Pubmed

Activation of the Wnt-beta catenin pathway in a cell population on the surface of the forebrain is essential for the establishment of olfactory axon connections.

FZD1 FZD4 FZD7 FZD9

1.16e-0627102417804636
Pubmed

Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes.

FZD1 FZD7 FZD2

2.03e-069102323095888
Pubmed

Partial interchangeability of Fz3 and Fz6 in tissue polarity signaling for epithelial orientation and axon growth and guidance.

FZD1 FZD6 FZD2

3.97e-0611102325294940
Pubmed

ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.

FZD4 FZD6 FZD5

3.97e-0611102322575959
Pubmed

Role of chromatin remodeling gene Cecr2 in neurulation and inner ear development.

FZD1 FZD7 FZD2

6.86e-0613102321246654
Pubmed

Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia.

FFAR3 GPR42

8.52e-062102225637492
Pubmed

Selective tracking of FFAR3-expressing neurons supports receptor coupling to N-type calcium channels in mouse sympathetic neurons.

FFAR3 GPR42

8.52e-062102230478340
Pubmed

Intestinal FFA3 mediates obesogenic effects in mice on a Western diet.

FFAR3 GPR42

8.52e-062102235858247
Pubmed

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.

FFAR3 GPR42

8.52e-062102222506074
Pubmed

Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization.

FZD4 FZD9

8.52e-062102214688793
Pubmed

Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype.

SLC6A4 SLC45A2

8.52e-062102220381161
Pubmed

The effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41.

FFAR3 GPR42

8.52e-062102224748202
Pubmed

Ca2(+)-dependent interaction of N-copine, a member of the two C2 domain protein family, with OS-9, the product of a gene frequently amplified in osteosarcoma.

CPNE6 OS9

8.52e-062102210403379
Pubmed

ER reorganization is remarkably induced in COS-7 cells accumulating transmembrane protein receptors not competent for export from the endoplasmic reticulum.

CHRNA4 FZD4

8.52e-062102225086772
Pubmed

The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity.

FFAR3 GPR42

8.52e-062102236362376
Pubmed

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids.

FFAR3 GPR42

8.52e-062102220399779
Pubmed

Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B.

FZD5 FZD2

8.52e-062102229748286
Pubmed

Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content.

FFAR3 GPR42

8.52e-062102223110765
Pubmed

The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation.

FFAR3 GPR42

8.52e-062102226522986
Pubmed

Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

FFAR3 GPR42

8.52e-062102227664183
Pubmed

G protein coupled receptor 41 regulates fibroblast activation in pulmonary fibrosis via Gαi/o and downstream Smad2/3 and ERK1/2 phosphorylation.

FFAR3 GPR42

8.52e-062102237019194
Pubmed

Planar cell polarity genes frizzled4 and frizzled6 exert patterning influence on arterial vessel morphogenesis.

FZD4 FZD6

8.52e-062102228253274
Pubmed

3-(4-Hydroxy-3-methoxyphenyl) propionic acid contributes to improved hepatic lipid metabolism via GPR41.

FFAR3 GPR42

8.52e-062102238040866
Pubmed

Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer's Disease Mouse Model.

FFAR3 GPR42

8.52e-062102235408893
Pubmed

FFAR3 modulates insulin secretion and global gene expression in mouse islets.

FFAR3 GPR42

8.52e-062102226091414
Pubmed

GPR41 modulates insulin secretion and gene expression in pancreatic β-cells and modifies metabolic homeostasis in fed and fasting states.

FFAR3 GPR42

8.52e-062102227550964
Pubmed

Free fatty acid receptor 3 differentially contributes to β-cell compensation under high-fat diet and streptozotocin stress.

FFAR3 GPR42

8.52e-062102232073900
Pubmed

Expression of frizzled genes in mouse costochondral chondrocytes.

FZD1 FZD9

8.52e-062102211334716
Pubmed

Melanocyte stem cells express receptors for canonical Wnt-signaling pathway on their surface.

FZD4 FZD7

8.52e-062102220450888
Pubmed

Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia.

FZD6 FZD9

8.52e-062102219179304
Pubmed

A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones.

SCUBE1 SCUBE3

8.52e-062102215234972
Pubmed

Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42.

FFAR3 GPR42

8.52e-062102219630535
Pubmed

Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts.

FZD1 FZD2

8.52e-062102220189955
Pubmed

Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells.

PDGFRB SLC6A4

8.52e-062102221186266
Pubmed

Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41.

FFAR3 GPR42

8.52e-062102214722361
Pubmed

Cloning of a melatonin-related receptor from human pituitary.

GPR50 MTNR1B

8.52e-06210228647286
Pubmed

Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?

SCUBE1 SCUBE3

8.52e-062102228238185
Pubmed

Scube regulates synovial angiogenesis-related signaling.

SCUBE2 SCUBE3

8.52e-062102224084593
Pubmed

Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed.

FFAR3 GPR42

8.52e-062102226260360
Pubmed

Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung.

FZD6 FZD7 FZD2

1.09e-0515102315617677
Pubmed

Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall.

FZD1 FZD4 FZD7

1.62e-0517102325727890
Pubmed

SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling.

SCUBE1 SCUBE2 SCUBE3

1.94e-0518102333308444
Pubmed

The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.

FFAR3 GPR42

2.55e-053102212496283
Pubmed

Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells.

YES1 LYN

2.55e-053102217692281
Pubmed

Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

FFAR3 GPR42

2.55e-053102223665276
Pubmed

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer.

FFAR3 GPR42

2.55e-053102234210970
Pubmed

Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3.

FFAR3 GPR42

2.55e-053102231719611
Pubmed

Frizzled7 functions as a Wnt receptor in intestinal epithelial Lgr5(+) stem cells.

FZD7 FZD5

2.55e-053102225892522
Pubmed

Evaluation of GPR50, hMel-1B, and ROR-alpha melatonin-related receptors and the etiology of adolescent idiopathic scoliosis.

GPR50 MTNR1B

2.55e-053102220733416
Pubmed

Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.

FFAR3 GPR42

2.55e-053102225581519
InteractionSCUBE1 interactions

SCUBE1 SCUBE2 SCUBE3

9.45e-075933int:SCUBE1
InteractionOR1D4 interactions

AGPAT4 FZD6 FZD7 FZD2

5.88e-0626934int:OR1D4
InteractionIGSF9B interactions

YES1 HNRNPL LYN

1.12e-0510933int:IGSF9B
InteractionANXA6 interactions

CAV1 SIRT7 HNRNPL CPNE6 FZD5 MTNR1B

2.06e-05121936int:ANXA6
InteractionSCGB1C1 interactions

FZD1 FZD7 FZD2

2.63e-0513933int:SCGB1C1
InteractionCLEC2D interactions

GPR50 GPR42 AGPAT4 XYLT2 SUSD1 FASTKD3 FZD2

3.57e-05197937int:CLEC2D
InteractionWNT7B interactions

HNRNPL FZD1 FZD4

6.17e-0517933int:WNT7B
InteractionPLPP1 interactions

GPR42 CHRNA4 HNRNPL

6.17e-0517933int:PLPP1
InteractionWNT7A interactions

FZD7 FZD9 FZD5 OS9

7.08e-0548934int:WNT7A
CytobandEnsembl 112 genes in cytogenetic band chr11q14

TRIM64 FZD4 TRIM64B MTNR1B

4.37e-041561034chr11q14
Cytoband3p22.3

CMTM6 OSBPL10

2.22e-033110323p22.3
Cytoband11q14.3

TRIM64 TRIM64B

2.37e-0332103211q14.3
Cytoband11q24.1

OR10G6 OR4D5

3.15e-0337103211q24.1
CytobandEnsembl 112 genes in cytogenetic band chr7q31

LAMB4 CAV1 CPED1

3.93e-031401033chr7q31
GeneFamilyG protein-coupled receptors, Class F frizzled

FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

1.28e-1411857286
GeneFamilyG protein-coupled receptors, Class A orphans

GPR19 GPR65 GPR50 GPR42

4.98e-0478854262
GeneFamilyLaminin subunits

LAMB4 LAMA2

1.40e-0312852626
GeneFamilyATAC complex

ZZZ3 KAT14

1.65e-03138521058
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

SUSD1 ACAN C1S

2.44e-03578531179
GeneFamilyCholinergic receptors nicotinic subunits

CHRNA4 CHRNE

2.51e-0316852173
GeneFamilyArmadillo repeat containing|Importins

TNPO2 IPO11

3.18e-0318852596
GeneFamilyOlfactory receptors, family 10

OR10D3 OR10G6 OR10G3

3.71e-0366853157
ToppCellPND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDGFRB ECM2 LAMA2 CPED1 C1S FZD2 NEXN

3.72e-071961037119265efd2219f328d8152dbee52af8327aec89c
ToppCellTracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ECM2 LAMA2 GRIK3 SCUBE1 SCUBE3 C1S FZD2

3.85e-0719710372cb1f557ce1400398975de94638126b4522567f3
ToppCellLPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type

PDGFRB LAMA2 CPED1 FRMD4A ACAN ATP1A4 NEXN

4.26e-0720010378c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GABRG1 ANK1 TRIM64 CPED1 TRIM64B ACAN

2.63e-0616810362eed7dc1a2aff11be024823c4323c42bc94362f6
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DIRAS1 LINC02898 LIFR C1S ATP1A4 ALPK2

2.72e-061691036559e98216720e4babf0b0941100f1b485c35b11b
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GABRG1 AGPAT4 CPED1 PPP4R4 SCUBE2 NEXN

2.81e-061701036e20568c8f3f17d94de78229617eb2f7e4c5af2bc
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB LINC02898 ECM2 LAMA2 C1S NEXN

4.04e-061811036c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB LINC02898 ECM2 LAMA2 C1S NEXN

4.04e-061811036c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCellNS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

STAB2 DPY19L2 BEST3 SLC6A4 FZD7 SCUBE2

4.30e-061831036ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CAV1 YES1 CPED1 LYST LIFR IPO11

4.72e-0618610360ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellmoderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

STAB2 DPY19L2 BEST3 CHRNE SLC6A4 SCUBE2

5.17e-0618910366011b747e27d61d222380a7bffdd921a68e9b657
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GABRG1 PDGFRB CAV1 CPED1 FZD7 ACAN

5.17e-061891036fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCelldroplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ECM2 CPED1 LYST FZD6 LIFR IPO11

5.17e-061891036fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB ECM2 LAMA2 CPED1 C1S NEXN

5.50e-061911036a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB ECM2 LAMA2 CPED1 C1S NEXN

5.50e-0619110368f6d592edc32fdb901af30501d4360512334e8c2
ToppCellfacs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB ECM2 LAMA2 CPED1 C1S FZD2

5.66e-061921036a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PDGFRB ECM2 LAMA2 CPED1 C1S FZD2

5.66e-0619210367b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCellfacs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB ECM2 LAMA2 CPED1 C1S FZD2

5.66e-061921036eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

STAB2 FZD6 FZD9 TLL1 LYN IPO11

5.66e-0619210365388f3115ab285f3f3001af1d71543ed64b9e044
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CAV1 YES1 FZD4 LIFR FRMD4A SCUBE1

5.66e-0619210364bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PDGFRB ECM2 LAMA2 CPED1 C1S FZD2

5.66e-06192103632acd89617934016cd135d2cc797e8e79ae1b37f
ToppCellfacs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB ECM2 LAMA2 CPED1 C1S FZD2

5.83e-061931036d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

STAB2 FZD6 FZD9 TLL1 LYN IPO11

5.83e-061931036ef007b736da56529ec628fc3df86a335e7ec3f18
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ECM2 CAV1 CHRNA4 SCUBE1 C1S NEXN

6.01e-06194103691205b22650e7ecdb72bb59348ce2530b76c532c
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ECM2 CAV1 CHRNA4 SCUBE1 C1S NEXN

6.01e-0619410366e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ECM2 CAV1 CHRNA4 SCUBE1 C1S NEXN

6.01e-061941036c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCell(3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

STAB2 ECM2 LAMA2 FZD1 FZD9 FZD2

6.19e-061951036f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDGFRB ECM2 CPED1 SCUBE3 FZD2 NEXN

6.19e-06195103656e7cd980f8fc2dae842e6a7bd919d4b41cebbbb
ToppCellFibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id

PDGFRB CAV1 CPED1 FRMD4A ACAN NEXN

6.19e-061951036c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCelltumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass

PDGFRB CAV1 CPED1 ACAN C1S NEXN

6.19e-061951036ea9ff25020c2fcd1bab80e1829af0f4e4777de8b
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PDGFRB ECM2 CPED1 SCUBE3 FZD2 NEXN

6.19e-061951036a28a504c69bc4dda7de023e1b4ea4f62390b158e
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

STAB2 DPY19L2 BEST3 CHRNE SCUBE2 SLC45A2

6.37e-061961036a4cc02ea41479d24044bd2ca6441f85d683c0ca9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB ECM2 LAMA2 CPED1 ACAN NEXN

6.37e-0619610361522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

STAB2 DPY19L2 BEST3 CHRNE SCUBE2 SLC45A2

6.37e-06196103650aaca81b593ff71790bb75403b2e4c3ab03a6d2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB ECM2 LAMA2 CPED1 ACAN NEXN

6.37e-0619610361c8294014713684b50885e638668f2ce75f357f0
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CAV1 LYST FZD4 SLC6A4 LIFR TLL1

6.56e-0619710368437c33e2c4a10a1b95343431e48d5e820b1f742
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PDGFRB ECM2 LAMA2 FZD4 C1S NEXN

6.56e-0619710363bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CAV1 LYST FZD4 SLC6A4 LIFR TLL1

6.56e-0619710360542badae77d2f606c13cfaf361319495c354351
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PDGFRB ECM2 LAMA2 FZD4 C1S NEXN

6.56e-06197103617344464fdcc5ba0c03959696b97c195f11e644c
ToppCell343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells)

PDGFRB ECM2 CAV1 CPED1 SCUBE3 NEXN

6.56e-06197103678d45d11820ec379942c4c3defd619d5f8cc8e1f
ToppCell3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAV1 FZD4 FZD6 LIFR TLL1 IPO11

6.56e-0619710367a1a3839b2c965136663241b0d4e96c64cfb656a
ToppCell343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells)

PDGFRB ECM2 CAV1 CPED1 SCUBE3 NEXN

6.56e-06197103631bc9fd679d78550541d4158568e8dd09ff29e8e
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PDGFRB ECM2 LAMA2 FZD4 C1S NEXN

6.56e-0619710365b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CAV1 LYST FZD4 SLC6A4 LIFR TLL1

6.56e-061971036a6a64581699cfcb9607b288976fa3b09648725b7
ToppCellParenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDGFRB ECM2 LAMA2 FZD1 SCUBE1 C1S

6.75e-061981036300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAV1 FZD4 FZD6 LIFR TLL1 IPO11

6.75e-06198103613203249e5743ba2699871c184d141207e550a86
ToppCellcellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CAV1 LYST FZD4 SLC6A4 LIFR TLL1

6.95e-06199103668412bc39639edc4045437d62548f7101b9f1989
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PDGFRB FRMD4A CPNE6 ACAN ATP1A4 NEXN

7.15e-0620010369169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell(5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

PDGFRB ECM2 LAMA2 CAV1 C1S NEXN

7.15e-06200103622c839f27d3abdf86bfabdfa305f205dd899a9dc
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PDGFRB LAMA2 CPED1 ACAN ATP1A4 NEXN

7.15e-062001036b22cae282591d8dead9869c2adbb9632615f50f7
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PDGFRB CPED1 FRMD4A CPNE6 ACAN ATP1A4

7.15e-062001036c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCellLPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type

PDGFRB LAMA2 CPED1 ACAN ATP1A4 NEXN

7.15e-0620010368bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCellLPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PDGFRB LAMA2 CPED1 ACAN ATP1A4 NEXN

7.15e-06200103677631c471cc5d453a749784f838cfa6408caf09b
ToppCellprimary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PDGFRB ECM2 LAMA2 CPED1 FZD6

3.03e-051551035ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCellprimary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PDGFRB ECM2 LAMA2 CPED1 FZD6

3.03e-0515510350f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCellprimary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PDGFRB ECM2 LAMA2 CPED1 FZD6

3.03e-051551035d8b5145258f075b15080f8739f537f48dd22225e
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DPY19L2 FZD4 FRMD4A SCUBE3 SLC45A2

3.13e-0515610354d2679e7639758c49fc25a2deb9109b08f0a3e57
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB CAV1 CPED1 C1S NEXN

3.43e-051591035cfb4a8c8aac34b1a857956d98382d487abcf5444
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB CAV1 CPED1 C1S NEXN

3.43e-051591035a75ab494959575143cefdaec99e7aee3f318d559
ToppCellBL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

BEST3 SLC6A4 FZD7 SCUBE2 SCUBE3

4.71e-051701035b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCellBronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

BEST3 CHRNE SLC6A4 FZD7 SCUBE2

5.12e-051731035e1de849dcd96063136bdac87e050ddbd55cabdcc
ToppCellBronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

BEST3 CHRNE SLC6A4 FZD7 SCUBE2

5.12e-051731035f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDGFRB LAMA2 FZD1 C1S NEXN

5.41e-0517510351799a7be623dc3bf53ba580a7c47d2619969d708
ToppCellwk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

FZD9 CPNE6 ACAN SCUBE3 FZD2

5.41e-051751035a84965d28438a4228d841b357c2cd75cf4b59a63
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass

ECM2 LAMA2 C1S USH2A FZD2

5.56e-05176103508f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCelldroplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB KCNH3 SLC6A4 SCUBE3 NEXN

5.71e-051771035dbdbdc8ed9ef0b529694242ef9f9f07a42e16005
ToppCelltumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass

LAMB4 STAB2 CAV1 KCNH3 SLC6A4

5.71e-051771035f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCellFetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DPY19L2 PDGFRB CAV1 CPED1 ACAN

5.86e-051781035066dbc4cc2083c549d98122ed44707127f34d582
ToppCelldroplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB KCNH3 SLC6A4 SCUBE3 NEXN

5.86e-051781035416f85e51f45ec7949451fd47611a84e33e87245
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LINC02898 CAV1 SCUBE1 FZD2 NEXN

6.02e-051791035d5e3e7f1cd8f683f39a7416f12af7e766dcbead8
ToppCellNS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

STAB2 DPY19L2 BEST3 SLC6A4 SCUBE2

6.18e-0518010358af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCellMatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4)

AGPAT4 CPED1 PPP4R4 SCUBE2 NEXN

6.18e-051801035adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

DPY19L2 LAMA2 CPED1 NEXN ALPK2

6.34e-051811035719eb532453ab7cd7893726885bc75d74a10b21e
ToppCellASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

CATSPERD CAV1 SLC6A4 FZD2 NEXN

6.51e-051821035ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCelldroplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB ECM2 LAMA2 FZD1 C1S

6.51e-051821035f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LYST FZD4 FZD6 LIFR TLL1

6.51e-051821035d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell3'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAV1 PPM1J FZD7 SLC45A2 ALOX12B

6.51e-051821035b4f347fb684f6840c166d7473f3f56389f69c14b
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LAMA2 PPM1J KIAA0825 C1S TAF2

6.68e-051831035269afec240a756eec3bbae5f30ec784281af3433
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 ANK1 GRIK3 ATP1A4 USH2A

6.86e-0518410352cbed6462fea2622871bb7e49b0df3d984239281
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

ECM2 LAMA2 NEK1 TLL1 TRAM2

6.86e-05184103567164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCellcritical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

STAB2 DPY19L2 BEST3 SLC6A4 SCUBE2

6.86e-05184103558d36577eff814d46d72f031f3533d71549e3d6e
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 ANK1 GRIK3 ATP1A4 USH2A

6.86e-051841035ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 ANK1 GRIK3 ATP1A4 USH2A

6.86e-0518410352b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class

PDGFRB LAMA2 CAV1 CPED1 C1S

6.86e-05184103586a96cd88e50eacad1f0badfbbf6dc626f41725e
ToppCellCOVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

DPY19L2 LAMA2 CPED1 NEXN ALPK2

7.04e-051851035549eeb521c3985bff396ea0f202db21822efa51f
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DPY19L2 PDGFRB ECM2 CAV1 ACAN

7.04e-05185103535d39a1d04c871edcfb749653538dc5fd0054281
ToppCellEndothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

CYP1A1 CAV1 FZD4 LIFR TLL1

7.04e-051851035dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCelldroplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB ECM2 LAMA2 FZD1 C1S

7.22e-05186103535c88cc4eb388811fcac4323b549e5897fa8dc27
ToppCelldroplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB ECM2 LAMA2 FZD1 C1S

7.22e-051861035d998c5b00083cf2a7cd5341a98b7374b4de73c63
ToppCelldroplet-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP1A1 CAV1 FZD6 LIFR TLL1

7.40e-05187103564dd28b23eda7dfb7fd069be2742de7bad0fd87a
ToppCelldroplet-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP1A1 CAV1 FZD6 LIFR TLL1

7.40e-051871035b535d5447bf15e95dcf025a0a455628b956fc857
ToppCellP15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PDGFRB ECM2 LAMA2 SCUBE2 NEXN

7.59e-051881035f1ba0b661621a65c91432e62ba73531bdf18e7c1
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB CAV1 CPED1 ACAN NEXN

7.59e-051881035b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

PDGFRB ECM2 LAMA2 FZD1 LIFR

7.59e-051881035de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCellFibroblast-A|World / shred on cell class and cell subclass (v4)

AGPAT4 CPED1 PPP4R4 SCUBE2 NEXN

7.59e-0518810356740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 BEST3 GRIK3 CPED1 ACAN

7.59e-0518810358de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB CAV1 CPED1 FRMD4A ACAN

7.78e-0518910357fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCelldroplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ECM2 CPED1 LYST LIFR IPO11

7.78e-0518910358e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB CAV1 CPED1 FRMD4A ACAN

7.78e-05189103506b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDGFRB CAV1 CPED1 ACAN NEXN

7.78e-051891035127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ComputationalGenes in the cancer module 27.

GPR65 PDGFRB GRIK3 CHRNA4 CHRNE FZD9 LIFR FZD5 FZD2

7.01e-05355559MODULE_27
Drugclofazimine

LYST FZD1 FZD4 FZD7 FZD9 FZD2

9.03e-09351006CID000002794
DrugPrestwick_517

PDGFRB FZD1 FZD4 FZD6 FZD7 FZD9 FZD5 FZD2

2.21e-081061008CID000003804
DrugA 172

FZD1 FZD4 FZD6 FZD7 FZD5 FZD2

6.44e-07701006CID000014025
DrugAC1L9M5J

GRIK3 FZD1 FZD4 FZD6 FZD7 TK2 FZD5 FZD2

6.00e-062211008CID000448615
DrugAC1L3MB7

CYP1A1 C1S SLC45A2

2.28e-05131003CID000091556
DrugParoxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A

ZNF573 STAB2 LAMA2 PPP4R4 FRMD4A TK2 ACAN

2.48e-0519510073821_DN
DrugSolanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A

LAMB4 STAB2 CAV1 CHRNE TK2 C1S SLC45A2

2.48e-0519510072152_UP
DrugTriamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A

TNPO2 CPED1 LYST FRMD4A P2RY4 ACAN KRT37

2.65e-0519710072241_UP
DrugThiocolchicoside [602-41-5]; Up 200; 7uM; PC3; HT_HG-U133A

TNPO2 AGPAT4 PPP4R4 FZD1 TK2 ACAN C1S

2.74e-0519810075095_UP
Diseasebreast carcinoma (is_marker_for)

PDGFRB CAV1 FZD1 FZD2

7.04e-0566984DOID:3459 (is_marker_for)
Diseaseinsulin sensitivity measurement, insulin response measurement

ANK1 MTNR1B

3.02e-048982EFO_0004471, EFO_0008473
Diseaseinsulin response measurement

ANK1 MTNR1B

3.87e-049982EFO_0008473
DiseaseDepressed mood

CHRNA4 SLC6A4

8.32e-0413982C0344315
Diseasecongenital myasthenic syndrome (implicated_via_orthology)

CHRNA4 CHRNE

1.27e-0316982DOID:3635 (implicated_via_orthology)
DiseaseSeasonal Affective Disorder

GPR50 SLC6A4

1.27e-0316982C0085159
DiseaseSystemic Scleroderma

SIRT7 XYLT2

1.80e-0319982C0036421
Diseasefactor VIII measurement, Ischemic stroke

STAB2 STXBP5

1.80e-0319982EFO_0004630, HP_0002140
Diseasestem Cell Growth Factor beta measurement

STAB2 AGPAT4 SCYL2

2.02e-0375983EFO_0008292
DiseaseAlcoholic Intoxication, Chronic

GABRG1 GRIK3 CHRNA4 SLC6A4 IPO11

2.03e-03268985C0001973
DiseaseDisproportionate short stature

LIFR NEK1 ACAN

2.17e-0377983C0878659
Diseaseosteoarthritis (biomarker_via_orthology)

CAV1 ACAN

2.20e-0321982DOID:8398 (biomarker_via_orthology)
DiseaseInfiltrating duct carcinoma of female breast

PDGFRB PKN1

2.20e-0321982C3165106
Diseasecomplement factor H-related protein 3 measurement

LIFR NEK1 ACAN USH2A

2.47e-03169984EFO_0600056
Diseasesystemic scleroderma (is_implicated_in)

CAV1 HNRNPL

2.87e-0324982DOID:418 (is_implicated_in)
DiseaseAutism Spectrum Disorders

GPR50 MTNR1B USH2A

2.88e-0385983C1510586

Protein segments in the cluster

PeptideGeneStartEntry
VDVVVCVIYSPGEFY

TDRD1

716

Q9BXT4
SIYCDRYAEQIPVTF

BEST3

66

Q8N1M1
CAEIYPDITYAFVIR

CHRNA4

226

P43681
ISIVDPYYSYCQLET

CATSPERD

691

Q86XM0
YYCEVPFDVVTVTIG

CPED1

596

A4D0V7
SDYELCPEITLTYTE

ALPK2

306

Q86TB3
VCRIITTDFPLYFVI

ANK1

1051

P16157
LLSICIDRFYTIVYP

GPR19

156

Q15760
RVYSIYVHTVCDPLF

CAV1

146

Q03135
FVQAVIPTIEYDYTR

ATG3

296

Q9NT62
PAIYRSVCAVEVTYF

CHRNE

141

Q04844
CVLAEVPRQVVEYYA

CPNE6

521

O95741
PYRYVVVSVTNVICA

CYP1A1

186

P04798
IERGETYCLYLPETF

NEXN

631

Q0ZGT2
LYVAVTVPYSVCVST

KCNH3

236

Q9ULD8
DRYTAVCQPLLYVTI

OR9Q2

121

Q8NGE9
DFLYNIPVSTCVEYE

KIAA0825

881

Q8IV33
TVELARTCIGTPYYL

NEK1

156

Q96PY6
TVCPDYQSYFRTIEE

KRT37

146

O76014
FFTYPTLTEICRRLV

IPO11

356

Q9UI26
LEYDPRIYSCTFIQT

MTNR1B

181

P49286
IGTIEYDPRTYTCIF

GPR50

166

Q13585
CPFIYIIRKDVDVYS

NUP85

51

Q9BW27
SECLQYPDFSVVVLY

KAT14

666

Q9H8E8
SVLYTVPATIVIACY

FZD2

466

Q14332
VPATIVIACYFYEQA

FZD2

471

Q14332
VTDTECLTLYNIYPR

LAMA2

171

P24043
VTVVTVYYVPCAFIY

OR10G3

246

Q8NGC4
RYTDFDTLIYTCAPE

DPY19L2

466

Q6NUT2
VLFVVPLIITSYCYS

GPR42

191

O15529
VDLIVYLRTNPETCY

TK2

176

O00142
RPSTETYDVYCFVDR

ACAN

561

P16112
ICAYLVEYSPSRIRE

PPP4R3C

386

Q6ZMV5
VCFVPFHITRTIYYL

P2RY4

256

P51582
YIPTIEDTYRQVISC

DIRAS1

36

O95057
SVLYTVPATIVIACY

FZD1

541

Q9UP38
VPATIVIACYFYEQA

FZD1

546

Q9UP38
VPATCVIACYFYEIS

FZD4

446

Q9ULV1
LYTVPASIVVACYLY

FZD5

456

Q13467
ERPIIYYSVCYSIVS

FZD6

231

O60353
VLYTVPATIVLACYF

FZD7

476

O75084
TVPATCVIVCYVYER

FZD9

456

O00144
GPVVLYFCVRFYIES

FRMD4A

91

Q9P2Q2
INIVRFYEVYCDVAP

DNAH17

3246

Q9UFH2
GYFTIQTYIPCILTV

GABRG1

271

Q8N1C3
YIPTVEDTYRQVISC

DIRAS2

36

Q96HU8
VLFVVPLIITSYCYS

FFAR3

191

O14843
RTSYPESETFIVYLC

LINC02898

101

Q6ZV80
TLFGSVIRYTCEEPY

C1S

376

P09871
YFTLTRVDRSCPYLT

FRMD6-AS1

21

P0C7T7
YIKIREIPSYTFSCI

ECM2

671

O94769
LLIESLSVVYTTYCP

LYST

1736

Q99698
PELIRYVTIVIYTCS

ALOX12B

561

O75342
YAVVTREEPIYIITE

LYN

306

P07948
TTFEVYVEVAYPRTG

DENND1A

11

Q8TEH3
NPIYSITTDVLYTIC

HNRNPL

201

P14866
ICLEPDVQYSIDVYF

LAMB4

676

A4D0S4
VICASYYPSREQERI

DCST2

526

Q5T1A1
VSCVLFVIARFSPYE

GRIK3

576

Q13003
ITTYETCQTYERPIA

SCUBE1

866

Q8IWY4
SVTTYETCQTYERPI

SCUBE2

876

Q9NQ36
SITTYETCQTYERPI

SCUBE3

871

Q8IX30
EFCYAVEAAYVTPVL

SLC45A2

46

Q9UMX9
PYTLYTFRIRCSTET

LIFR

501

P42702
VVTLIFVPCIYVYTR

OR4D5

246

Q8NGN0
PIYIITEYCRYGDLV

PDGFRB

676

P09619
DRFTAICYPLRYTVI

OR10D3

121

Q8NH80
LTVVIVYYVPCTFIY

OR10G6

266

Q8NH81
YVAICSPLRYTTILT

OR52H1

131

Q8NGJ2
CVTYVFFITSLIYPA

SLC29A3

311

Q9BZD2
PYRIYEFTITLCNSV

USH2A

1436

O75445
PVRYTIAICFYEVSK

PPP4R4

411

Q6NUP7
RSDEESYIVFTYRPC

TLL1

196

O43897
CIDRYIVVTDPLVYA

TAAR8

126

Q969N4
EVFEFYEEILTCRYP

TAF2

286

Q6P1X5
CSLETPVDSQLYRYV

FASTKD3

526

Q14CZ7
LSCFPEVRVYDLTQY

PPM1J

401

Q5JR12
EYLAPEYILSVSCET

SCYL2

231

Q6P3W7
VFSEPRAIFYSACVV

PKN1

711

Q16512
YIEVCTSCVPNREYV

SIRT7

191

Q9NRC8
DYSIVDFLTLCETPY

STXBP5

341

Q5T5C0
YIDRVDEPLSCSYVL

OS9

206

Q13438
PEERVICFVEYYLTA

OSBPL10

451

Q9BXB5
YFAPLDVVYCIVSEA

SRBD1

616

Q8N5C6
CAIPYSILIFVYDEI

ATP1A4

996

Q13733
LIVYCTPFYERVDTT

CMTM6

86

Q9NX76
DLQCEIISYIEVPTY

ZNF573

101

Q86YE8
IIVAYDRYVAICTPL

OR4E2

116

Q8NGC2
CKSPVRTYERFTVTY

TRAPPC14

376

Q8WVR3
VVCLDLYPTTDYTVN

SUSD1

456

Q6UWL2
CFYVVVTEGYLTNPR

TRAM2

131

Q15035
EEACTELVPYLSYIL

TNPO2

506

O14787
CRYTFEVRTYSLSLP

STAB2

71

Q8WWQ8
TCIAVDRYLAVVYPL

GPR65

106

Q8IYL9
VCTYRDFIYRTVEIP

TSHB

71

P01222
TECTIFTDPRAYLKY

AGPAT4

71

Q9NRZ5
PCYISLSEDVRYVIF

TRIM64

296

A6NGJ6
TIDTVSVPYVFRYFV

POLR1B

1106

Q9H9Y6
FICIPTYIAYRLIIT

SLC6A4

586

P31645
LTVEDPVTVEYITRY

PSMA7

96

O14818
PCYISLSEDVRYVIF

TRIM64B

296

A6NI03
FDVRSYLLIACTTPY

TTLL10

376

Q6ZVT0
PIYRSETFLDRDYCV

ZZZ3

871

Q8IYH5
IDPTYVVATSYDITV

XYLT2

691

Q9H1B5
YAVVSEEPIYIVTEF

YES1

336

P07947